[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2003/76440,2003,A1Locationinpatent:Page/Pagecolumn67
[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2011/213003,2011,A1Locationinpatent:Page/Pagecolumn76
1357247-55-2
59855-96-8
1080060-60-1
1909309-55-2
2155854-96-7
1330754-00-1 | Ethyl 5-isopropyl-1,3,4-thiadiazole-2-carboxylate | AA01B7RA | MFCD19981641
36053-94-8 | 8-Methyl-1,2,3,4-tetrahydroquinolin-4-one | AA01B7W1 | MFCD09054821
1803560-91-9 | [3-(tert-butoxy)cyclobutyl]hydrazine hydrochloride | AA01B828 | MFCD28246395
76670-20-7 | 5,6,7,8-tetrahydroquinolin-8-ylmethanol | AA01B876 | MFCD18803034
1041604-47-0 | 5-bromo-N-[2-(pyridin-2-yl)ethyl]pyridin-2-amine | AA01B8C8 | MFCD11122303
1803589-57-2 | methyl 4-formyl-3-methyl-1H-pyrrole-2-carboxylate | AA01B8H7 | MFCD28246540
1803585-39-8 | 3-[(4-chlorophenyl)methyl]oxolan-3-amine hydrochloride | AA01B8LT | MFCD28246583
1504251-86-8 | 5-(propan-2-yl)-1-benzofuran-3-carboxylic acid | AA01B8RH | MFCD21281682
132710-75-9 | O-(1-methylpiperidin-4-yl)hydroxylamine dihydrochloride | AA01B8VU | MFCD28348175
912846-55-0 | 6-amino-5-fluoro-1,2,3,4-tetrahydroisoquinolin-1-one | AA01B913 | MFCD20702794